BUENA, N.J., May 07, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1st quarter 2018 financial results and business update. This call will be rescheduled for 8:30am ET on Tuesday, May 8, 2018.
The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.
This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com


Welspun Corp Shares Hit Record High on $1.8 Billion U.S. Order
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
OpenAI Tightens AI Safety Monitoring After Security Incidents
Barclays Downgrades Renault as Cost Savings Challenges Grow
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Samsung Shares Rise on $72 Billion Shareholder Return Plan
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Alibaba Shares Fall as AI Spending Hits Profit 



